Price in deferred time of 15 minutes
|
Last quote
10/23/2024 -
17:31:42
|
Bid
10/23/2024 -
19:30:58
|
Bid Volume |
Ask
10/23/2024 -
17:19:42
|
Ask Volume |
|---|---|---|---|---|
|
5.06
-0.74
(
-12.76% )
|
4.91
|
200 |
5.12
|
329 |
Analysis date: 18.10.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 20.09.2024.
Interest
Very weak
Very weak
Very weak interest since 18.10.2024.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 27.09.2024 at a price of 4.40.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 06.08.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
8.13%
8.13%
The four week relative overperformance versus STOXX600 is 8.13%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 25.06.2024.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.27%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.68%.
Mkt Cap in $bn
0.19
0.19
With a market capitalization <$2bn, MOLECULAR PARTNERS is considered a small-cap stock.
G/PE Ratio
-4.51
-4.51
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-1.63
-1.63
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-7.37%
-7.37%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
58
58
For 1% of index variation, the stock varies on average by 0.58%.
Correlation
0.07
0.07
Stock movements are totally independent of index variations.
Value at Risk
1.07
1.07
The value at risk is estimated at CHF 1.07. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
12.08.2016
12.08.2016